Target Gene/Pathway💬 Info on mouse-over

132 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 Acute myeloid leukemia 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
2 Adipocytokine signaling pathway 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
3 Adipocytokine signaling pathway 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
4 Adrenergic signaling in cardiomyocytes 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
5 Adrenergic signaling in cardiomyocytes 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
6 African trypanosomiasis 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
7 AGE-RAGE signaling pathway in diabetic complications 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
8 AGE-RAGE signaling pathway in diabetic complications 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
9 AGE-RAGE signaling pathway in diabetic complications 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
10 Aldosterone synthesis and secretion 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
11 Aldosterone synthesis and secretion 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
12 Allograft rejection 💬
[1] IL5 💬 D04923 💬 Mepolizumab [4] 44, 45, 98, 162 💬
13 Allograft rejection 💬
[1] IL5 💬 D08985 💬 Reslizumab [2] 44, 98 💬
14 Allograft rejection 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
15 Alzheimer disease 💬
[3] CHRM1, CHRM3, CHRM5 💬 D01000 💬 Bethanechol [1] 98 💬
16 Alzheimer disease 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
17 Alzheimer disease 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
18 Amoebiasis 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
19 AMPK signaling pathway 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
20 Amyotrophic lateral sclerosis 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
21 Amyotrophic lateral sclerosis 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
22 Antifolate resistance 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
23 Antigen processing and presentation 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
24 Apelin signaling pathway 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
25 Apelin signaling pathway 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
26 Apelin signaling pathway 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
27 Apoptosis 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
28 Asthma 💬
[1] FCER1A 💬 D05251 💬 Omalizumab [7] 46, 53, 65, 98, 162, 226, 299 💬
29 Asthma 💬
[1] IL5 💬 D04923 💬 Mepolizumab [4] 44, 45, 98, 162 💬
30 Asthma 💬
[1] IL5 💬 D08985 💬 Reslizumab [2] 44, 98 💬
31 Asthma 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
32 Autoimmune thyroid disease 💬
[1] IL5 💬 D04923 💬 Mepolizumab [4] 44, 45, 98, 162 💬
33 Autoimmune thyroid disease 💬
[1] IL5 💬 D08985 💬 Reslizumab [2] 44, 98 💬
34 Autophagy - animal 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
35 Autophagy - other 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
36 Breast cancer 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
37 C-type lectin receptor signaling pathway 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
38 Calcium signaling pathway 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
39 Calcium signaling pathway 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
40 Calcium signaling pathway 💬
[4] CHRM1, CHRM2, CHRM3, CHRM5 💬 D01000 💬 Bethanechol [1] 98 💬
41 Calcium signaling pathway 💬
[1] CYSLTR1 💬 D00529 💬 Montelukast [5] 13, 46, 85, 98, 228 💬
42 Calcium signaling pathway 💬
[1] CYSLTR1 💬 D08229 💬 Montelukast [5] 13, 46, 85, 98, 228 💬
43 Calcium signaling pathway 💬
[1] HRH1 💬 D01172 💬 Diphenylpyraline [1] 98 💬
44 Calcium signaling pathway 💬
[1] HRH1 💬 D01627 💬 Diphenylpyraline [1] 98 💬
45 Calcium signaling pathway 💬
[1] HRH1 💬 D07862 💬 Diphenylpyraline [1] 98 💬
46 Calcium signaling pathway 💬
[1] HRH1 💬 D00364 💬 Loratadine [3] 13, 46, 98 💬
47 Calcium signaling pathway 💬
[1] HRH2 💬 D00318 💬 Famotidine [4]  6 , 46, 86, 98 💬
48 cAMP signaling pathway 💬
[2] CHRM1, CHRM2 💬 D01000 💬 Bethanechol [1] 98 💬
49 Cellular senescence 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
50 Central carbon metabolism in cancer 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
51 cGMP-PKG signaling pathway 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
52 cGMP-PKG signaling pathway 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
53 Chagas disease 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
54 Choline metabolism in cancer 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
55 Cholinergic synapse 💬
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 D01000 💬 Bethanechol [1] 98 💬
56 Collecting duct acid secretion 💬
[2] ATP4A, ATP4B 💬 D08903 💬 Dexlansoprazole [1] 98 💬
57 Collecting duct acid secretion 💬
[2] ATP4A, ATP4B 💬 D01984 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
58 Collecting duct acid secretion 💬
[2] ATP4A, ATP4B 💬 D04056 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
59 Collecting duct acid secretion 💬
[2] ATP4A, ATP4B 💬 D07917 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
60 Collecting duct acid secretion 💬
[2] ATP4A, ATP4B 💬 D09339 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
61 Collecting duct acid secretion 💬
[2] ATP4A, ATP4B 💬 D00355 💬 Lansoprazole [7] 63, 71, 85, 98, 166, 222, 299 💬
62 Collecting duct acid secretion 💬
[2] ATP4A, ATP4B 💬 D00455 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
63 Collecting duct acid secretion 💬
[2] ATP4A, ATP4B 💬 D01207 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
64 Collecting duct acid secretion 💬
[2] ATP4A, ATP4B 💬 D05259 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
65 Collecting duct acid secretion 💬
[2] ATP4A, ATP4B 💬 D05261 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
66 Collecting duct acid secretion 💬
[2] ATP4A, ATP4B 💬 D11784 💬 Vonoprazan [2] 63, 98 💬
67 Colorectal cancer 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
68 Coronavirus disease - COVID-19 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
69 Coronavirus disease - COVID-19 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
70 Coronavirus disease - COVID-19 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
71 Cortisol synthesis and secretion 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
72 Cortisol synthesis and secretion 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
73 Cushing syndrome 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
74 Cushing syndrome 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
75 Cytokine-cytokine receptor interaction 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
76 Cytokine-cytokine receptor interaction 💬
[1] IL5 💬 D04923 💬 Mepolizumab [4] 44, 45, 98, 162 💬
77 Cytokine-cytokine receptor interaction 💬
[1] IL5 💬 D08985 💬 Reslizumab [2] 44, 98 💬
78 Cytokine-cytokine receptor interaction 💬
[1] IL5RA 💬 D09874 💬 Benralizumab [4] 44, 45, 98, 162 💬
79 Cytokine-cytokine receptor interaction 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
80 Diabetic cardiomyopathy 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
81 Diabetic cardiomyopathy 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
82 Diabetic cardiomyopathy 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
83 Dilated cardiomyopathy 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
84 EGFR tyrosine kinase inhibitor resistance 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
85 Endocrine resistance 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
86 Epstein-Barr virus infection 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
87 ErbB signaling pathway 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
88 Fc epsilon RI signaling pathway 💬
[1] FCER1A 💬 D05251 💬 Omalizumab [7] 46, 53, 65, 98, 162, 226, 299 💬
89 Fc epsilon RI signaling pathway 💬
[1] IL5 💬 D04923 💬 Mepolizumab [4] 44, 45, 98, 162 💬
90 Fc epsilon RI signaling pathway 💬
[1] IL5 💬 D08985 💬 Reslizumab [2] 44, 98 💬
91 Fc epsilon RI signaling pathway 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
92 Fluid shear stress and atherosclerosis 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
93 GABAergic synapse 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol [9]  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
94 Gastric acid secretion 💬
[2] ATP4A, ATP4B 💬 D08903 💬 Dexlansoprazole [1] 98 💬
95 Gastric acid secretion 💬
[2] ATP4A, ATP4B 💬 D01984 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
96 Gastric acid secretion 💬
[2] ATP4A, ATP4B 💬 D04056 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
97 Gastric acid secretion 💬
[2] ATP4A, ATP4B 💬 D07917 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
98 Gastric acid secretion 💬
[2] ATP4A, ATP4B 💬 D09339 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
99 Gastric acid secretion 💬
[2] ATP4A, ATP4B 💬 D00355 💬 Lansoprazole [7] 63, 71, 85, 98, 166, 222, 299 💬
100 Gastric acid secretion 💬
[2] ATP4A, ATP4B 💬 D00455 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
101 Gastric acid secretion 💬
[2] ATP4A, ATP4B 💬 D01207 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
102 Gastric acid secretion 💬
[2] ATP4A, ATP4B 💬 D05259 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
103 Gastric acid secretion 💬
[2] ATP4A, ATP4B 💬 D05261 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
104 Gastric acid secretion 💬
[2] ATP4A, ATP4B 💬 D11784 💬 Vonoprazan [2] 63, 98 💬
105 Gastric acid secretion 💬
[1] CHRM3 💬 D01000 💬 Bethanechol [1] 98 💬
106 Gastric acid secretion 💬
[1] HRH2 💬 D00318 💬 Famotidine [4]  6 , 46, 86, 98 💬
107 Gastric cancer 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
108 Glioma 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
109 Graft-versus-host disease 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
110 Growth hormone synthesis, secretion and action 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
111 Hematopoietic cell lineage 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
112 Hematopoietic cell lineage 💬
[1] IL5 💬 D04923 💬 Mepolizumab [4] 44, 45, 98, 162 💬
113 Hematopoietic cell lineage 💬
[1] IL5 💬 D08985 💬 Reslizumab [2] 44, 98 💬
114 Hematopoietic cell lineage 💬
[1] IL5RA 💬 D09874 💬 Benralizumab [4] 44, 45, 98, 162 💬
115 Hematopoietic cell lineage 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
116 Hepatitis B 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
117 Hepatitis C 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
118 Hepatocellular carcinoma 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
119 Herpes simplex virus 1 infection 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
120 Herpes simplex virus 1 infection 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
121 HIF-1 signaling pathway 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
122 Human cytomegalovirus infection 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
123 Human cytomegalovirus infection 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
124 Human immunodeficiency virus 1 infection 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
125 Human immunodeficiency virus 1 infection 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
126 Human papillomavirus infection 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
127 Human papillomavirus infection 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
128 Human T-cell leukemia virus 1 infection 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
129 Huntington disease 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
130 Hypertrophic cardiomyopathy 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
131 IL-17 signaling pathway 💬
[1] IL5 💬 D04923 💬 Mepolizumab [4] 44, 45, 98, 162 💬
132 IL-17 signaling pathway 💬
[1] IL5 💬 D08985 💬 Reslizumab [2] 44, 98 💬
133 IL-17 signaling pathway 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
134 Inflammatory bowel disease 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
135 Inflammatory bowel disease 💬
[1] IL5 💬 D04923 💬 Mepolizumab [4] 44, 45, 98, 162 💬
136 Inflammatory bowel disease 💬
[1] IL5 💬 D08985 💬 Reslizumab [2] 44, 98 💬
137 Inflammatory bowel disease 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
138 Inflammatory mediator regulation of TRP channels 💬
[1] HRH1 💬 D01172 💬 Diphenylpyraline [1] 98 💬
139 Inflammatory mediator regulation of TRP channels 💬
[1] HRH1 💬 D01627 💬 Diphenylpyraline [1] 98 💬
140 Inflammatory mediator regulation of TRP channels 💬
[1] HRH1 💬 D07862 💬 Diphenylpyraline [1] 98 💬
141 Inflammatory mediator regulation of TRP channels 💬
[1] HRH1 💬 D00364 💬 Loratadine [3] 13, 46, 98 💬
142 Influenza A 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
143 Insulin resistance 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
144 Insulin resistance 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
145 Insulin secretion 💬
[1] CHRM3 💬 D01000 💬 Bethanechol [1] 98 💬
146 Insulin signaling pathway 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
147 Intestinal immune network for IgA production 💬
[1] IL5 💬 D04923 💬 Mepolizumab [4] 44, 45, 98, 162 💬
148 Intestinal immune network for IgA production 💬
[1] IL5 💬 D08985 💬 Reslizumab [2] 44, 98 💬
149 JAK-STAT signaling pathway 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
150 JAK-STAT signaling pathway 💬
[1] IL5 💬 D04923 💬 Mepolizumab [4] 44, 45, 98, 162 💬
151 JAK-STAT signaling pathway 💬
[1] IL5 💬 D08985 💬 Reslizumab [2] 44, 98 💬
152 JAK-STAT signaling pathway 💬
[1] IL5RA 💬 D09874 💬 Benralizumab [4] 44, 45, 98, 162 💬
153 JAK-STAT signaling pathway 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
154 Kaposi sarcoma-associated herpesvirus infection 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
155 Legionellosis 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
156 Leishmaniasis 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
157 Longevity regulating pathway 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
158 Longevity regulating pathway - multiple species 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
159 Malaria 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
160 MAPK signaling pathway 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
161 Metabolic pathways 💬
[2] ATP4A, ATP4B 💬 D08903 💬 Dexlansoprazole [1] 98 💬
162 Metabolic pathways 💬
[2] ATP4A, ATP4B 💬 D01984 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
163 Metabolic pathways 💬
[2] ATP4A, ATP4B 💬 D04056 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
164 Metabolic pathways 💬
[2] ATP4A, ATP4B 💬 D07917 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
165 Metabolic pathways 💬
[2] ATP4A, ATP4B 💬 D09339 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
166 Metabolic pathways 💬
[2] ATP4A, ATP4B 💬 D00355 💬 Lansoprazole [7] 63, 71, 85, 98, 166, 222, 299 💬
167 Metabolic pathways 💬
[2] ATP4A, ATP4B 💬 D00455 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
168 Metabolic pathways 💬
[2] ATP4A, ATP4B 💬 D01207 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
169 Metabolic pathways 💬
[2] ATP4A, ATP4B 💬 D05259 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
170 Metabolic pathways 💬
[2] ATP4A, ATP4B 💬 D05261 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
171 Metabolic pathways 💬
[2] ATP4A, ATP4B 💬 D11784 💬 Vonoprazan [2] 63, 98 💬
172 MicroRNAs in cancer 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
173 Morphine addiction 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol [9]  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
174 mTOR signaling pathway 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
175 mTOR signaling pathway 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
176 Natural killer cell mediated cytotoxicity 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
177 Necroptosis 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
178 Neuroactive ligand-receptor interaction 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
179 Neuroactive ligand-receptor interaction 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
180 Neuroactive ligand-receptor interaction 💬
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 D01000 💬 Bethanechol [1] 98 💬
181 Neuroactive ligand-receptor interaction 💬
[1] CYSLTR1 💬 D00529 💬 Montelukast [5] 13, 46, 85, 98, 228 💬
182 Neuroactive ligand-receptor interaction 💬
[1] CYSLTR1 💬 D08229 💬 Montelukast [5] 13, 46, 85, 98, 228 💬
183 Neuroactive ligand-receptor interaction 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol [9]  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
184 Neuroactive ligand-receptor interaction 💬
[1] HRH1 💬 D01172 💬 Diphenylpyraline [1] 98 💬
185 Neuroactive ligand-receptor interaction 💬
[1] HRH1 💬 D01627 💬 Diphenylpyraline [1] 98 💬
186 Neuroactive ligand-receptor interaction 💬
[1] HRH1 💬 D07862 💬 Diphenylpyraline [1] 98 💬
187 Neuroactive ligand-receptor interaction 💬
[1] HRH1 💬 D00364 💬 Loratadine [3] 13, 46, 98 💬
188 Neuroactive ligand-receptor interaction 💬
[1] HRH2 💬 D00318 💬 Famotidine [4]  6 , 46, 86, 98 💬
189 Neuroactive ligand-receptor interaction 💬
[1] NR3C1 💬 D00689 💬 Beclomethasone dipropionate [3] 85, 97, 98 💬
190 Neuroactive ligand-receptor interaction 💬
[1] NR3C1 💬 D07495 💬 Beclomethasone dipropionate [3] 85, 97, 98 💬
191 Neuroactive ligand-receptor interaction 💬
[1] NR3C1 💬 D00246 💬 Budesonide [9] 66, 93, 94, 95, 96, 97, 98, 228, 299 💬
192 Neuroactive ligand-receptor interaction 💬
[1] NR3C1 💬 D07981 💬 Fluticasone [3] 98, 228, 299 💬
193 Neuroactive ligand-receptor interaction 💬
[1] NR3C1 💬 D01708 💬 Fluticasone propionate [2] 98, 228 💬
194 Neuroactive ligand-receptor interaction 💬
[1] NR3C1 💬 D00690 💬 Mometasone [2] 98, 162 💬
195 Neuroactive ligand-receptor interaction 💬
[1] NR3C1 💬 D03325 💬 Mometasone [2] 98, 162 💬
196 Neuroactive ligand-receptor interaction 💬
[1] NR3C1 💬 D08227 💬 Mometasone [2] 98, 162 💬
197 Neuroactive ligand-receptor interaction 💬
[1] NR3C1 💬 D00690 💬 Mometasone furoate [2] 98, 162 💬
198 Neutrophil extracellular trap formation 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
199 NF-kappa B signaling pathway 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
200 Nicotine addiction 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol [9]  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
201 NOD-like receptor signaling pathway 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
202 Non-alcoholic fatty liver disease 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
203 Osteoclast differentiation 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
204 Oxidative phosphorylation 💬
[2] ATP4A, ATP4B 💬 D08903 💬 Dexlansoprazole [1] 98 💬
205 Oxidative phosphorylation 💬
[2] ATP4A, ATP4B 💬 D01984 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
206 Oxidative phosphorylation 💬
[2] ATP4A, ATP4B 💬 D04056 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
207 Oxidative phosphorylation 💬
[2] ATP4A, ATP4B 💬 D07917 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
208 Oxidative phosphorylation 💬
[2] ATP4A, ATP4B 💬 D09339 💬 Esomeprazole [6] 13, 46, 86, 98, 298, 299 💬
209 Oxidative phosphorylation 💬
[2] ATP4A, ATP4B 💬 D00355 💬 Lansoprazole [7] 63, 71, 85, 98, 166, 222, 299 💬
210 Oxidative phosphorylation 💬
[2] ATP4A, ATP4B 💬 D00455 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
211 Oxidative phosphorylation 💬
[2] ATP4A, ATP4B 💬 D01207 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
212 Oxidative phosphorylation 💬
[2] ATP4A, ATP4B 💬 D05259 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
213 Oxidative phosphorylation 💬
[2] ATP4A, ATP4B 💬 D05261 💬 Omeprazole [16]  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
214 Oxidative phosphorylation 💬
[2] ATP4A, ATP4B 💬 D11784 💬 Vonoprazan [2] 63, 98 💬
215 Pancreatic cancer 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
216 Pancreatic secretion 💬
[1] CHRM3 💬 D01000 💬 Bethanechol [1] 98 💬
217 Pathogenic Escherichia coli infection 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
218 Pathways in cancer 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
219 Pathways in cancer 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
220 Pathways in cancer 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
221 Pathways in cancer 💬
[1] IL5 💬 D04923 💬 Mepolizumab [4] 44, 45, 98, 162 💬
222 Pathways in cancer 💬
[1] IL5 💬 D08985 💬 Reslizumab [2] 44, 98 💬
223 Pathways in cancer 💬
[1] IL5RA 💬 D09874 💬 Benralizumab [4] 44, 45, 98, 162 💬
224 Pathways in cancer 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
225 Pathways of neurodegeneration - multiple diseases 💬
[3] CHRM1, CHRM3, CHRM5 💬 D01000 💬 Bethanechol [1] 98 💬
226 Pathways of neurodegeneration - multiple diseases 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
227 Pathways of neurodegeneration - multiple diseases 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
228 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
229 Pertussis 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
230 Phospholipase D signaling pathway 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
231 Phospholipase D signaling pathway 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
232 Phospholipase D signaling pathway 💬
[1] FCER1A 💬 D05251 💬 Omalizumab [7] 46, 53, 65, 98, 162, 226, 299 💬
233 Phospholipase D signaling pathway 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
234 PI3K-Akt signaling pathway 💬
[2] CHRM1, CHRM2 💬 D01000 💬 Bethanechol [1] 98 💬
235 PI3K-Akt signaling pathway 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
236 PI3K-Akt signaling pathway 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
237 Prion disease 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
238 Prostate cancer 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
239 Proteoglycans in cancer 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
240 Proteoglycans in cancer 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
241 Regulation of actin cytoskeleton 💬
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 D01000 💬 Bethanechol [1] 98 💬
242 Renin secretion 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
243 Renin secretion 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
244 Renin-angiotensin system 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
245 Renin-angiotensin system 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
246 Retrograde endocannabinoid signaling 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol [9]  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
247 Rheumatoid arthritis 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
248 RIG-I-like receptor signaling pathway 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
249 Salivary secretion 💬
[1] CHRM3 💬 D01000 💬 Bethanechol [1] 98 💬
250 Salmonella infection 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
251 Serotonergic synapse 💬
[3] GABRB1, GABRB2, GABRB3 💬 D00549 💬 Propofol [9]  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
252 Shigellosis 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
253 Shigellosis 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
254 Sphingolipid signaling pathway 💬
[1] FCER1A 💬 D05251 💬 Omalizumab [7] 46, 53, 65, 98, 162, 226, 299 💬
255 Sphingolipid signaling pathway 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
256 Spinocerebellar ataxia 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
257 Systemic lupus erythematosus 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
258 T cell receptor signaling pathway 💬
[1] IL5 💬 D04923 💬 Mepolizumab [4] 44, 45, 98, 162 💬
259 T cell receptor signaling pathway 💬
[1] IL5 💬 D08985 💬 Reslizumab [2] 44, 98 💬
260 T cell receptor signaling pathway 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
261 Taste transduction 💬
[1] CHRM3 💬 D01000 💬 Bethanechol [1] 98 💬
262 Taste transduction 💬
[6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬 D00549 💬 Propofol [9]  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
263 TGF-beta signaling pathway 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
264 Th1 and Th2 cell differentiation 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
265 Th1 and Th2 cell differentiation 💬
[1] IL5 💬 D04923 💬 Mepolizumab [4] 44, 45, 98, 162 💬
266 Th1 and Th2 cell differentiation 💬
[1] IL5 💬 D08985 💬 Reslizumab [2] 44, 98 💬
267 Th17 cell differentiation 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
268 Th17 cell differentiation 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
269 Thermogenesis 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
270 Thyroid hormone signaling pathway 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
271 TNF signaling pathway 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
272 Toll-like receptor signaling pathway 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
273 Toxoplasmosis 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
274 Tuberculosis 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
275 Type I diabetes mellitus 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
276 Type II diabetes mellitus 💬
[1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
277 Type II diabetes mellitus 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
278 Vascular smooth muscle contraction 💬
[1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
279 Vascular smooth muscle contraction 💬
[1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
280 Viral protein interaction with cytokine and cytokine receptor 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
281 Yersinia infection 💬
[1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬